These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28550044)

  • 1. T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model.
    Woods DM; Woan KV; Cheng F; Sodré AL; Wang D; Wu Y; Wang Z; Chen J; Powers J; Pinilla-Ibarz J; Yu Y; Zhang Y; Wu X; Zheng X; Weber J; Hancock WW; Seto E; Villagra A; Yu XZ; Sotomayor EM
    Blood; 2017 Jul; 130(2):146-155. PubMed ID: 28550044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tbet is a critical modulator of FoxP3 expression in autoimmune graft-
    Amarnath S; Laurence A; Zhu N; Cunha R; Eckhaus MA; Taylor S; Foley JE; Ghosh M; Felizardo TC; Fowler DH
    Haematologica; 2017 Aug; 102(8):1446-1456. PubMed ID: 28473623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.
    Leigh ND; O'Neill RE; Du W; Chen C; Qiu J; Ashwell JD; McCarthy PL; Chen GL; Cao X
    J Immunol; 2017 Jul; 199(1):336-347. PubMed ID: 28550198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated onset and increased severity of acute graft-versus-host disease following adoptive transfer of DR6-deficient T cells.
    Liu J; Heuer JG; Na S; Galbreath E; Zhang T; Yang DD; Glasebrook A; Song HY
    J Immunol; 2002 Oct; 169(7):3993-8. PubMed ID: 12244201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.
    Long M; Slaiby AM; Hagymasi AT; Mihalyo MA; Lichtler AC; Reiner SL; Adler AJ
    J Immunol; 2006 Jan; 176(2):1036-45. PubMed ID: 16393991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function.
    Sahakian E; Powers JJ; Chen J; Deng SL; Cheng F; Distler A; Woods DM; Rock-Klotz J; Sodre AL; Youn JI; Woan KV; Villagra A; Gabrilovich D; Sotomayor EM; Pinilla-Ibarz J
    Mol Immunol; 2015 Feb; 63(2):579-85. PubMed ID: 25155994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.
    He S; Xie F; Liu Y; Tong Q; Mochizuki K; Lapinski PE; Mani RS; Reddy P; Mochizuki I; Chinnaiyan AM; Mineishi S; King PD; Zhang Y
    Blood; 2013 Dec; 122(25):4119-28. PubMed ID: 24141370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B).
    Araki Y; Fann M; Wersto R; Weng NP
    J Immunol; 2008 Jun; 180(12):8102-8. PubMed ID: 18523274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
    Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
    Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.
    Liu Y; Wu Y; Wang Y; Cai Y; Hu B; Bao G; Fang H; Zhao L; Ma S; Cheng Q; Song Y; Liu Y; Zhu Z; Chang H; Yu X; Sun A; Zhang Y; Vignali DA; Wu D; Liu H
    Leukemia; 2015 Apr; 29(4):939-46. PubMed ID: 25363669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.
    Furusawa A; Reiser J; Sadashivaiah K; Simpson H; Banerjee A
    J Immunother; 2018; 41(2):53-63. PubMed ID: 29271784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expression.
    Lüking C; Kronenberger K; Frankenberger B; Nössner E; Röcken M; Mocikat R
    Int J Cancer; 2008 May; 122(10):2280-5. PubMed ID: 18224683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing T-cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model.
    Friedman JS; Alpdogan O; van den Brink MR; Liu C; Hurwitz D; Boyd A; Kupper TS; Burakoff SJ
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):448-60. PubMed ID: 15205666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.
    Besançon A; Demir Z; Goncalves T; Valette F; Panafieu E; Chatenoud L; You S
    Transplantation; 2018 Sep; 102(9):1496-1504. PubMed ID: 29757902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells.
    Chen L; He W; Kim ST; Tao J; Gao Y; Chi H; Intlekofer AM; Harvey B; Reiner SL; Yin Z; Flavell RA; Craft J
    J Immunol; 2007 Mar; 178(5):2730-6. PubMed ID: 17312115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.
    Fu J; Wu Y; Nguyen H; Heinrichs J; Schutt S; Liu Y; Liu C; Jin J; Anasetti C; Yu XZ
    J Immunol; 2016 Apr; 196(7):3168-79. PubMed ID: 26903480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.
    Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
    J Immunol; 2016 Aug; 197(3):726-35. PubMed ID: 27324129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.